| Recruitment status | Open public recruiting |
| Unique ID issued by UMIN | UMIN000024619 |
| Receipt No. | R000028270 |
| Official scientific title of the study | Early response evaluation of chemotherapy in malignant lymphoma by contrast-enhanced ultrasonography |
| Date of disclosure of the study information | 2016/10/31 |
| Last modified on | 2016/10/29 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | Early response evaluation of chemotherapy in malignant lymphoma by contrast-enhanced ultrasonography | |
| Title of the study (Brief title) | Contrast-enhanced ultrasonography for malignant lymphoma | |
| Region |
|
|
| Condition | |||
| Condition | malignant lymphoma | ||
| Classification by specialty |
|
||
| Classification by malignancy | Malignancy | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To evaluate predictive value of contrast-enhanced ultrasonography and elastography for early response of chemotherapy in malignant lymphoma, comparison with response rate |
| Basic objectives2 | Others |
| Basic objectives -Others | Comparison between contrast-enhanced ultrasonographic findings and contrast-enhanced CT findings. |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Comparison between some parameters (Time to peak, Area under the curve, etc.) obtained by contrast-enhanced ultrasonography 3, 7, 14 days after start of chemotherapy and response rate. |
| Key secondary outcomes | Comparison between tissue stiffness obtained by elastography 3, 7, 14 days after start of chemotherapy and response rate. |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) patients with histological confirmed malignant lymphoma
2) target lesion can be depicted by ultrasonography 3) hospiterized patient 4) patients who consented to participate in this study |
|||
| Key exclusion criteria | 1) history of allergy to Sonazoid
2) history of allergy to egg 3) not eligible for this study judged by doctors |
|||
| Target sample size | 50 | |||
| Research contact person | |
| Name of lead principal investigator | Naoki Matsumoto |
| Organization | Nihon University School of Medicine, Itabashi Hospital |
| Division name | Division of Gastroenterology and Hepatology, Department of Medicine |
| Address | 30-1, Oyaguchi kamimachi, Itabashi-ku, Tokyo 173-8610, Japan. |
| TEL | 03-3972-8111 |
| matsumotosg7@gmail.com | |
| Public contact | |
| Name of contact person | Naoki Matsumoto |
| Organization | Nihon University School of Medicine, Itabashi Hospital |
| Division name | Division of Gastroenterology and Hepatology, Department of Medicine |
| Address | 30-1, Oyaguchi kamimachi, Itabashi-ku, Tokyo 173-8610, Japan. |
| TEL | 03-3972-8111 |
| Homepage URL | |
| matsumotosg7@gmail.com | |
| Sponsor | |
| Institute | Nihon University School of Medicine, Itabashi Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Nihon University School of Medicine, Itabashi Hospital |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Open public recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | Compare the findings of contrast-enhanced ultrasonography, before and 3, 7, 14 days after start of the chemotherapy for malignant lymphoma |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000028270 |